SWK Holdings CorporationSWK Holdings CorporationSWK Holdings Corporation

SWK Holdings Corporation

No trades
See on Supercharts
Market capitalization
‪212.95 M‬USD
‪15.89 M‬USD
‪36.96 M‬USD
‪12.26 M‬
Beta (1Y)
0.15

About SWK Holdings Corporation

Sector
CEO
Joe David Staggs
Headquarters
Dallas
Employees (FY)
23
Founded
1996
ISIN
US78501P2039
FIGI
BBG000BTX131
SWK Holdings Corp. engages in financial and asset management in the field of pharmaceuticals. The company offers capital and investments in life science companies, institutions, and inventors. It operates through the Finance Receivables and Pharmaceutical Development segments. The Finance Receivables segment is a healthcare capital provider which offers customized financing solutions to a broad range of life science companies, institutions, and investors. It is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. The Pharmaceutical Development segment strategy is to utilize the Peptelligence platform to create a wholly-owned portfolio of milestone and royalty income by out-licensing the technology. The company was founded in July 1996 and is headquartered in Dallas, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SWKH is 17.33 USD — it has increased by 1.70% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange SWK Holdings Corporation stocks are traded under the ticker SWKH.
SWK Holdings Corporation is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for SWK Holdings Corporation has a max estimate of 22.00 USD and a min estimate of 22.00 USD.
SWKH earnings for the last quarter are 0.38 USD whereas the estimation was 0.42 USD which accounts for −7.93% surprise. Estimated earnings for the next quarter are 0.43 USD. See more details about SWK Holdings Corporation earnings.
SWK Holdings Corporation revenue for the last quarter amounts to ‪8.96 M‬ USD despite the estimated figure of ‪9.30 M‬ USD. In the next quarter revenue is expected to reach ‪9.40 M‬ USD.
Yes, you can track SWK Holdings Corporation financials in yearly and quarterly reports right on TradingView.
Like other stocks, SWKH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SWK Holdings Corporation stock right from TradingView charts — choose your broker and connect to your account.
SWKH reached its all-time high on Mar 10, 2000 with the price of 17550.00 USD, and its all-time low was 4.50 USD and was reached on May 1, 2009.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 23.00 employees. See our rating of the largest employees — is SWK Holdings Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SWK Holdings Corporation EBITDA is ‪24.48 M‬ USD, and current EBITDA margin is 61.07%. See more stats in SWK Holdings Corporation financial statements.